Atıf Formatları
Investigating the molecular mechanisms of paclitaxel resistance through PI3/Akt and EMT signaling pathways in MCF-7 breast cancer
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

Ö. Sönmez Et Al. , "Investigating the molecular mechanisms of paclitaxel resistance through PI3/Akt and EMT signaling pathways in MCF-7 breast cancer," 6th International BAU Drug Design Congress , İstanbul, Turkey, 2018

Sönmez, Ö. Et Al. 2018. Investigating the molecular mechanisms of paclitaxel resistance through PI3/Akt and EMT signaling pathways in MCF-7 breast cancer. 6th International BAU Drug Design Congress , (İstanbul, Turkey).

Sönmez, Ö., ÖZFİLİZ KILBAŞ, P., ARISAN, E. D., ÇOKER GÜRKAN, A., OBAKAN YERLİKAYA, P., & ÜNSAL, Z. N., (2018). Investigating the molecular mechanisms of paclitaxel resistance through PI3/Akt and EMT signaling pathways in MCF-7 breast cancer . 6th International BAU Drug Design Congress, İstanbul, Turkey

Sönmez, Özlem Et Al. "Investigating the molecular mechanisms of paclitaxel resistance through PI3/Akt and EMT signaling pathways in MCF-7 breast cancer," 6th International BAU Drug Design Congress, İstanbul, Turkey, 2018

Sönmez, Özlem Et Al. "Investigating the molecular mechanisms of paclitaxel resistance through PI3/Akt and EMT signaling pathways in MCF-7 breast cancer." 6th International BAU Drug Design Congress , İstanbul, Turkey, 2018

Sönmez, Ö. Et Al. (2018) . "Investigating the molecular mechanisms of paclitaxel resistance through PI3/Akt and EMT signaling pathways in MCF-7 breast cancer." 6th International BAU Drug Design Congress , İstanbul, Turkey.

@conferencepaper{conferencepaper, author={Özlem Sönmez Et Al. }, title={Investigating the molecular mechanisms of paclitaxel resistance through PI3/Akt and EMT signaling pathways in MCF-7 breast cancer}, congress name={6th International BAU Drug Design Congress}, city={İstanbul}, country={Turkey}, year={2018}}